Variant report

Variant	esv3378384
Chromosome Location	chr9:140498481-140501329
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:472)
CpG islands
(count:489)
Chromatin interactive
region (count:19)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:472 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF3	chr9:140500314-140500576	K562	blood:	n/a	n/a
2	ATF3	chr9:140499555-140499816	K562	blood:	n/a	chr9:140499631-140499640
3	BHLHE40	chr9:140499614-140499783	HepG2	liver:	n/a	n/a
4	BHLHE40	chr9:140500196-140500599	K562	blood:	n/a	chr9:140500319-140500335
5	BHLHE40	chr9:140499561-140499836	K562	blood:	n/a	n/a
6	BHLHE40	chr9:140499598-140499770	GM12878	blood:	n/a	n/a
7	BHLHE40	chr9:140500257-140500479	GM12878	blood:	n/a	chr9:140500319-140500335
8	CCNT2	chr9:140499584-140499771	K562	blood:	n/a	chr9:140499637-140499646 chr9:140499631-140499640
9	CCNT2	chr9:140500097-140500918	K562	blood:	n/a	n/a
10	CEBPB	chr9:140500278-140500292	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr9:140500560-140501005	ECC-1	luminal epithelium:	n/a	n/a
12	CEBPB	chr9:140499663-140499773	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr9:140500713-140500961	Hela-S3	cervix:	n/a	n/a
14	CEBPD	chr9:140500087-140500279	HepG2	liver:	n/a	n/a
15	CEBPD	chr9:140500070-140500305	HepG2	liver:	n/a	n/a
16	CHD1	chr9:140500518-140500542	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD1	chr9:140500172-140500390	GM12878	blood:	n/a	n/a
18	CHD2	chr9:140500205-140500356	HepG2	liver:	n/a	n/a
19	CHD2	chr9:140499603-140499785	GM12878	blood:	n/a	n/a
20	CHD2	chr9:140499626-140499628	K562	blood:	n/a	n/a
21	CHD2	chr9:140499356-140501075	Hela-S3	cervix:	n/a	n/a
22	CHD2	chr9:140499635-140499748	H1-hESC	embryonic stem cell:	n/a	n/a
23	CHD2	chr9:140500526-140500554	K562	blood:	n/a	n/a
24	CREB1	chr9:140500506-140500843	A549	lung:	n/a	n/a
25	CREB1	chr9:140499423-140499860	A549	lung:	n/a	n/a
26	CREB1	chr9:140499561-140499826	ECC-1	luminal epithelium:	n/a	n/a
27	CREB1	chr9:140499393-140499927	H1-hESC	embryonic stem cell:	n/a	n/a
28	CREB1	chr9:140499402-140499916	K562	blood:	n/a	n/a
29	CREB1	chr9:140499420-140500497	HepG2	liver:	n/a	n/a
30	CREB1	chr9:140499409-140500377	GM12878	blood:	n/a	n/a
31	CREB1	chr9:140499418-140499904	H1-hESC	embryonic stem cell:	n/a	n/a
32	CTCF	chr9:140499640-140499790	GM06990	blood:	n/a	n/a
33	CTCF	chr9:140499669-140499721	Pancreas_OC	pancreas:	n/a	n/a
34	CTCF	chr9:140500693-140500819	GM12891	blood:	n/a	chr9:140500719-140500732
35	CTCF	chr9:140500127-140500242	GM12892	blood:	n/a	n/a
36	CTCF	chr9:140499628-140499774	Spleen_OC	spleen:	n/a	n/a
37	CTCF	chr9:140499687-140499744	GM10248	blood:	n/a	n/a
38	CTCF	chr9:140500760-140500910	GM12872	blood:	n/a	n/a
39	CTCF	chr9:140499680-140499830	GM12868	blood:	n/a	n/a
40	CTCF	chr9:140499665-140499782	NHEK	skin:	n/a	n/a
41	CTCF	chr9:140500173-140500250	GM19238	blood:	n/a	n/a
42	CTCF	chr9:140500495-140500496	GM10248	blood:	n/a	n/a
43	CTCF	chr9:140499655-140499759	GM19240	blood:	n/a	n/a
44	CTCF	chr9:140500131-140500190	NHEK	skin:	n/a	n/a
45	CTCF	chr9:140499620-140499770	HepG2	liver:	n/a	n/a
46	CTCF	chr9:140499623-140499625	Spleen_OC	spleen:	n/a	n/a
47	CTCF	chr9:140500451-140500489	GM10248	blood:	n/a	n/a
48	CTCF	chr9:140499640-140499790	Hela-S3	cervix:	n/a	n/a
49	CTCF	chr9:140499551-140499825	K562	blood:	n/a	n/a
50	CTCF	chr9:140499580-140499730	HMEC	breast:	n/a	n/a

(count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:140499397-140499447	LNCaP	prostate:	n/a
2	chr9:140499397-140499447	LNCaP	prostate:	n/a
3	chr9:140500813-140500863	HL-60	blood:	n/a
4	chr9:140499397-140499447	Jurkat	blood:	n/a
5	chr9:140500680-140500730	IMR90	lung:	fetal
6	chr9:140500037-140500087	SKMC	muscle:	n/a
7	chr9:140501305-140501355	LNCaP	prostate:	n/a
8	chr9:140500680-140500730	HepG2	liver:	n/a
9	chr9:140500037-140500087	NH-A	brain:	n/a
10	chr9:140499397-140499447	NHDF-neo	bronchial:	n/a
11	chr9:140500680-140500730	AoSMC	blood vessel:	n/a
12	chr9:140500680-140500730	HCT-116	colon:	n/a
13	chr9:140501305-140501355	Hela-S3	cervix:	n/a
14	chr9:140500813-140500863	AG04450	lung:	fetal
15	chr9:140501305-140501355	U87	brain:	n/a
16	chr9:140500813-140500863	Jurkat	blood:	n/a
17	chr9:140500208-140500258	HepG2	liver:	n/a
18	chr9:140499623-140499673	HAEpiC	amniotic membrane:	n/a
19	chr9:140500813-140500863	Hela-S3	cervix:	n/a
20	chr9:140500680-140500730	AG09309	skin:	n/a
21	chr9:140500037-140500087	AG04450	lung:	fetal
22	chr9:140499132-140499182	HCPEpiC	choroid plexus:	n/a
23	chr9:140500208-140500258	NHDF-neo	bronchial:	n/a
24	chr9:140499132-140499182	AG10803	skin:	n/a
25	chr9:140500813-140500863	AoSMC	blood vessel:	n/a
26	chr9:140499623-140499673	GM12878	blood:	n/a
27	chr9:140500037-140500087	AG04449	skin:	fetal
28	chr9:140499132-140499182	HCT-116	colon:	n/a
29	chr9:140499623-140499673	Hepatocyte	liver:	n/a
30	chr9:140499397-140499447	HUVEC	blood vessel:	n/a
31	chr9:140500680-140500730	SK-N-SH_RA	brain:	n/a
32	chr9:140500037-140500087	GM06990	blood:	n/a
33	chr9:140501305-140501355	HepG2	liver:	n/a
34	chr9:140500037-140500087	AG10803	skin:	n/a
35	chr9:140500037-140500087	BE2_C	brain:	n/a
36	chr9:140499623-140499673	HEK293	kidney:	embryo
37	chr9:140501305-140501355	GM12878	blood:	n/a
38	chr9:140499132-140499182	U87	brain:	n/a
39	chr9:140499623-140499673	HepG2	liver:	n/a
40	chr9:140499397-140499447	HPAEpiC	pulmonary alveolar:	n/a
41	chr9:140499623-140499673	NB4	blood:	n/a
42	chr9:140500680-140500730	CMK	blood:	n/a
43	chr9:140500037-140500087	HIPEpiC	eye:	n/a
44	chr9:140500208-140500258	AG10803	skin:	n/a
45	chr9:140500037-140500087	PFSK-1	brain:	n/a
46	chr9:140501305-140501355	HCM	heart:	n/a
47	chr9:140499397-140499447	HCT-116	colon:	n/a
48	chr9:140499132-140499182	CMK	blood:	n/a
49	chr9:140501305-140501355	Jurkat	blood:	n/a
50	chr9:140500813-140500863	GM12878	blood:	n/a

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:108745145..108746117-chr9:140500319..140500843,2	Hela-S3	cervix:
2	chr9:140480405..140490432-chr9:140494944..140502746,26	K562	blood:
3	chr9:140444055..140447780-chr9:140498087..140502451,7	MCF-7	breast:
4	chr9:140443479..140444983-chr9:140499290..140501657,2	K562	blood:
5	chr9:140482616..140489091-chr9:140495925..140503345,17	MCF-7	breast:
6	chr9:140443433..140448155-chr9:140497818..140502870,8	MCF-7	breast:
7	chr9:140470766..140479486-chr9:140497266..140502997,13	MCF-7	breast:
8	chr9:140470445..140476327-chr9:140498022..140503450,9	K562	blood:
9	chr9:140482416..140489757-chr9:140495738..140502746,21	K562	blood:
10	chr9:140447049..140448753-chr9:140497892..140500070,2	K562	blood:
11	chr9:140444986..140448753-chr9:140497892..140501428,4	K562	blood:
12	chr9:140491452..140494377-chr9:140498511..140500095,2	K562	blood:
13	chr9:140353049..140355083-chr9:140500607..140502657,2	K562	blood:
14	chr9:140477211..140479524-chr9:140496943..140498868,3	K562	blood:
15	chr9:140500723..140503070-chr9:140566116..140568927,3	K562	blood:
16	chr9:140498043..140499599-chr9:140558636..140561270,2	MCF-7	breast:
17	chr9:140470600..140473358-chr9:140498484..140501413,2	K562	blood:
18	chr2:219433435..219434245-chr9:140499709..140500590,2	Hela-S3	cervix:
19	chr17:56707742..56709303-chr9:140500647..140503505,2	MCF-7	breast:

No data

Variant related genes	Relation type
ARRDC1	TF binding region
ARRDC1	CpG island
ENSG00000165802	chromatin interactions
ENSG00000144580	chromatin interactions
ENSG00000198961	chromatin interactions
ENSG00000165724	chromatin interactions
ENSG00000130653	chromatin interactions
ENSG00000148399	chromatin interactions
ENSG00000212195	chromatin interactions
ENSG00000182154	chromatin interactions

Extended variants
information (count: 75 )
Associated
traits (count: 20 )

Variant overlapped rSNPs/rCNVs (count:75 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs369400465	chr9:140498566-140498567	Bivalent Enhancer Weak transcription Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs147878782	chr9:140498623-140498624	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs568619089	chr9:140498625-140498626	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs77289485	chr9:140498628-140498629	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs111406490	chr9:140498643-140498644	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs554454748	chr9:140498696-140498697	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs571036665	chr9:140498704-140498705	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs538775878	chr9:140498751-140498752	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs558654590	chr9:140498756-140498757	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs11789062	chr9:140498789-140498790	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs575335878	chr9:140498807-140498808	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs199504678	chr9:140498810-140498811	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs180804100	chr9:140498845-140498846	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs554538296	chr9:140498920-140498921	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs574687910	chr9:140498944-140498945	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs540496005	chr9:140498984-140498985	Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs575666389	chr9:140499019-140499020	Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs559947469	chr9:140499024-140499025	Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs141494141	chr9:140499027-140499028	Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs185021942	chr9:140499044-140499045	Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs562595193	chr9:140499062-140499063	Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs72765181	chr9:140499072-140499073	Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs548334770	chr9:140499109-140499110	Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs568439523	chr9:140499133-140499134	Flanking Active TSS Enhancers Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs368718276	chr9:140499266-140499267	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs189351399	chr9:140499267-140499268	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs375646762	chr9:140499268-140499269	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs548094861	chr9:140499347-140499348	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs181647662	chr9:140499371-140499372	Active TSS Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs111780743	chr9:140499421-140499422	Active TSS Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs540013851	chr9:140499557-140499558	Active TSS Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs546366831	chr9:140499567-140499568	Active TSS Weak transcription Bivalent/Poised TSS Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs4494021	chr9:140499646-140499647	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs537941885	chr9:140499648-140499649	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs554294094	chr9:140499654-140499655	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs186573104	chr9:140499855-140499856	Active TSS Weak transcription Bivalent/Poised TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs540171161	chr9:140500115-140500116	Active TSS Weak transcription Bivalent/Poised TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs553621923	chr9:140500121-140500122	Active TSS Weak transcription Bivalent/Poised TSS Enhancers	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs576630709	chr9:140500196-140500197	Active TSS Weak transcription Bivalent/Poised TSS Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs200306122	chr9:140500215-140500216	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs112727570	chr9:140500219-140500220	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs562332893	chr9:140500268-140500269	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs576509066	chr9:140500275-140500276	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs112163118	chr9:140500348-140500349	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs542288122	chr9:140500357-140500358	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs112319793	chr9:140500381-140500382	Bivalent/Poised TSS Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs527651007	chr9:140500441-140500442	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs117137535	chr9:140500443-140500444	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs376899985	chr9:140500474-140500475	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs564725780	chr9:140500494-140500495	Bivalent/Poised TSS Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:20)

Disease	PMID	Source
Leukemia	17361228	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Glioblastoma	16823260	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Cardiac fibroma	18329553	CNVD
Lung cancer	19147751	CNVD
Cervical cancer	17311676	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastric cancer	17908304	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Chordoma	18071362	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Sudden cardiac death	19188705	CNVD
Myoepithelioma	18604193	CNVD
Tuberous sclerosis	19566914	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Mantle cell lymphoma	19029149	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:474 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:140485800-140499000	Weak transcription	Right Atrium	heart
2	chr9:140485800-140499000	Weak transcription	Stomach Smooth Muscle	stomach
3	chr9:140486200-140498600	Weak transcription	Cortex derived primary cultured neurospheres	brain
4	chr9:140493200-140498600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr9:140493400-140498800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr9:140493400-140499000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr9:140493400-140499000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr9:140493400-140499000	Weak transcription	Gastric	stomach
9	chr9:140493600-140499000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr9:140496400-140498800	Enhancers	Primary hematopoietic stem cells short term culture	blood
11	chr9:140496400-140498800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
12	chr9:140496400-140499400	Enhancers	Primary monocytes fromperipheralblood	blood
13	chr9:140496600-140499000	Enhancers	K562	blood
14	chr9:140497000-140498800	Enhancers	Primary hematopoietic stem cells	blood
15	chr9:140497000-140499000	Enhancers	Brain Anterior Caudate	brain
16	chr9:140497400-140498800	Weak transcription	A549	lung
17	chr9:140497400-140499000	Enhancers	Brain Inferior Temporal Lobe	brain
18	chr9:140497400-140499400	Enhancers	Spleen	Spleen
19	chr9:140497600-140498600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr9:140497600-140498600	Weak transcription	Adipose Nuclei	Adipose
21	chr9:140497600-140498600	Weak transcription	Fetal Thymus	thymus
22	chr9:140497600-140499000	Enhancers	Monocytes-CD14+_RO01746	blood
23	chr9:140497600-140499600	Weak transcription	Brain Substantia Nigra	brain
24	chr9:140497600-140500200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
25	chr9:140497800-140498600	Weak transcription	Hela-S3	cervix
26	chr9:140497800-140498800	Weak transcription	Primary B cells from peripheral blood	blood
27	chr9:140497800-140498800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr9:140497800-140498800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr9:140497800-140498800	Enhancers	Brain Angular Gyrus	brain
30	chr9:140497800-140499000	Enhancers	Skeletal Muscle Male	skeletal muscle
31	chr9:140498000-140498600	Weak transcription	Brain Hippocampus Middle	brain
32	chr9:140498000-140498800	Weak transcription	Brain Cingulate Gyrus	brain
33	chr9:140498000-140499000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
34	chr9:140498000-140499000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
35	chr9:140498000-140499600	Enhancers	Skeletal Muscle Female	skeletal muscle
36	chr9:140498000-140500000	Weak transcription	Primary neutrophils fromperipheralblood	blood
37	chr9:140498200-140498600	Weak transcription	Primary B cells from cord blood	blood
38	chr9:140498200-140498600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
39	chr9:140498400-140498600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
40	chr9:140498400-140498600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr9:140498400-140498600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
42	chr9:140498400-140498600	Enhancers	Psoas Muscle	Psoas
43	chr9:140498400-140498600	Bivalent Enhancer	HepG2	liver
44	chr9:140498400-140498800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
45	chr9:140498400-140498800	Enhancers	Esophagus	oesophagus
46	chr9:140498400-140498800	Bivalent Enhancer	NHLF	lung
47	chr9:140498400-140499000	Enhancers	Breast Myoepithelial Primary Cells	Breast
48	chr9:140498400-140499000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
49	chr9:140498400-140499000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
50	chr9:140498400-140499000	Enhancers	HMEC	breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links